We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ventricular Catheter Flushing System Restores CSF Flow

By HospiMedica International staff writers
Posted on 06 Jun 2018
A non-invasive retrograde flushing system helps clinicians restore or increase cerebrospinal fluid (CSF) flow in a blocked ventricular catheter shunt.

The Anuncia (Lowell, MA, USA) Alivio System is designed to provide a non-invasive option for neurosurgeons to restore CSF flow in a non-flowing shunt, which may potentially avert emergency revision surgery. More...
The system, which can be used in conjunction with any CSF shunt flow-regulating valve and drainage catheter, is comprised of a flusher and a ventricular catheter (VC) with a unique relief membrane that restores or increase CSF flow in a and unblocks occluded inlet holes.

The flusher component does not regulate CSF flow in the implanted shunt system; instead, it allows fluid from the ventricular catheter to flows freely, without restriction through a passive flow channel. During flushing, the passive channel is manually occluded to create temporary one-way flow into the VC. After a controlled and limited fluid pulse is sent from the flusher, the flush dome refills with CSF from the VC and resumes free flowing fluid through the passive flow channel.

In the case of completely obstructed flow through the shunt, retrograde flushing of the VC is performed by depression of the flush dome, which sends a controlled and limited pulse of fluid--either native CSF or sterile saline introduced during a priming procedure before implant--into the VC. In a life-threatening case of a severely occluded catheter, the relief membrane of the VC opens to restore antigrade flow in the shunt system.

“If you have a shunt, you are always worried about what might happen in the future. Close to half of shunts will have a revision within the first year of implantation. About 80% will require a revision within 10 years,” said neurosurgeon Joseph Madsen, MD, co-inventor of the Alivio system. “I am delighted that my fellow neurosurgeons will have an option to intervene non-invasively when treating hydrocephalus patients who come in with complications related to ventricular shunt obstruction.”

Hydrocephalus is a condition in which an excess of CSF accumulates within the ventricles and increases pressure in the brain. But even as implanted CSF shunts help relieve the pressure build-up, according to the Hydrocephalus Association (Bethesda, MD, USA), at least 50% of patients suffer from shunt failures and blockages within two years, requiring repeated revision surgeries. The costs of these often-emergent, revision surgeries to restore CSF flow and alleviate painful symptoms present a heavy emotional and financial burden to patients, families, and healthcare facilities.

Related Links:
Anuncia
Hydrocephalus Association


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Electric Bed
DIXION Intensive Care Bed
New
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.